Recent Updates
Recently added Catalysts
HCA Neutral Sentiment

INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare reports FIRST quarter 2025 results Nashville, Tenn.

Friday, April 25, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: HCA Healthcare, Inc. has released its financial and operational results for the first quarter of 2025, ending March 31, 2025. The report highlights various key metrics but does not present specific figures or significant developments in the text provided. Further details regarding percentage changes and important performance indicators are expected to be included in the full report. This announcement follows the company's ongoing efforts to communicate its financial health to stakeholders.
Price reaction · baseline $341.41 (2025-04-24 close) · hit after-hours · clean, no other HCA news in the window
day 0 close · peak
-4%

Market Sentiment Analysis

Full Press Release Details

FOR IMMEDIATE RELEASE
INVESTOR CONTACT: MEDIA CONTACT:
Frank Morgan Harlow Sumerford
615-344-2688 615-344-1851
HCA Healthcare reports FIRST quarter 2025 results
Nashville, Tenn., April 25, 2025 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2025.
Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted):

Frequently Asked Questions

When did HCA Healthcare report its Q1 2025 results?

HCA Healthcare reported its Q1 2025 results on April 25, 2025.

What does NYSE: HCA stand for?

NYSE: HCA refers to HCA Healthcare, Inc.'s trading symbol on the New York Stock Exchange.

What is the date for HCA's first quarter ending?

The first quarter ended on March 31, 2025.

Who can be contacted for investor inquiries?

Frank Morgan is the contact for investor inquiries at HCA Healthcare.

Who should be contacted for media inquiries at HCA?

Harlow Sumerford is the contact for media inquiries at HCA Healthcare.

ShareAdd on Google
Tags: HCA Viatris Investor Conferences Healthcare healthcare financial results Q1 2025 Nashville
Last updated: Apr 25, 2025

Biotech snapshot

Cash runway
$1415M liquidity · $0M/mo burn
Low dilution risk